Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2E)-1-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG 7-amido-4-methylcoumarin, mixed-type inhibition | Severe acute respiratory syndrome-related coronavirus | |
(2E)-1-[2,4-dihydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG 7-amido-4-methylcoumarin, noncompetitive | Severe acute respiratory syndrome-related coronavirus | |
(2E)-1-[2-hydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG 7-amido-4-methylcoumarin, noncompetitive | Severe acute respiratory syndrome-related coronavirus | |
(2E)-1-[2-hydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG 7-amido-4-methylcoumarin, noncompetitive | Severe acute respiratory syndrome-related coronavirus | |
(2E)-1-[2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG 7-amido-4-methylcoumarin, noncompetitive | Severe acute respiratory syndrome-related coronavirus | |
(2E)-1-[3-(2-hydroperoxy-3-methylbut-3-en-1-yl)-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG 7-amido-4-methylcoumarin, noncompetitive | Severe acute respiratory syndrome-related coronavirus | |
(2E)-1-[3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG-7-amido-4-methyl coumarin, noncompetitive | Severe acute respiratory syndrome-related coronavirus | |
(2E)-1-[3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG 7-amido-4-methylcoumarin, noncompetitive | Severe acute respiratory syndrome-related coronavirus | |
(2E)-1-[3-[(2E)-6,6-dimethoxy-3-methylhex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | substrate: LRLRGG 7-amido-4-methylcoumarin, noncompetitive | Severe acute respiratory syndrome-related coronavirus | |
4,9-dimethoxy-7H-furo[3,2-g][1]benzopyran-7-one | deubiquitination activity, 0.2 mM, 80% inhibition | Severe acute respiratory syndrome-related coronavirus | |
4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one | deubiquitination activity, 0.2 mM, 30% inhibition | Severe acute respiratory syndrome-related coronavirus | |
7H-furo[3,2-g][1]benzopyran-7-one | deubiquitination activity, 0.2 mM, 40% inhibition | Severe acute respiratory syndrome-related coronavirus | |
9-methoxy-7H-furo[3,2-g][1]benzopyran-7-one | deubiquitination activity, 0.2 mM, 30% inhibition | Severe acute respiratory syndrome-related coronavirus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Severe acute respiratory syndrome-related coronavirus | - |
human, i.e. SARS-CoV | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
LRLRGG 7-amido-4-methylcoumarin + H2O | - |
Severe acute respiratory syndrome-related coronavirus | LRLRGG 7-amido-4-methylcoumarin | - |
? | |
[ISG15] 7-amido-4-methyl coumarin + H2O | - |
Severe acute respiratory syndrome-related coronavirus | ? | - |
? | |
[ubiquitin] 7-amido-4-methyl coumarin + H2O | - |
Severe acute respiratory syndrome-related coronavirus | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
papain-like protease | - |
Severe acute respiratory syndrome-related coronavirus |
PLpro | - |
Severe acute respiratory syndrome-related coronavirus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Severe acute respiratory syndrome-related coronavirus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
6.8 | - |
assay at | Severe acute respiratory syndrome-related coronavirus |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0056 | - |
7H-furo[3,2-g][1]benzopyran-7-one | DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | |
0.0121 | - |
4,9-dimethoxy-7H-furo[3,2-g][1]benzopyran-7-one | DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | |
0.013 | - |
4,9-dimethoxy-7H-furo[3,2-g][1]benzopyran-7-one | deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | |
0.018 | - |
7H-furo[3,2-g][1]benzopyran-7-one | deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | |
0.0188 | - |
4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one | DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | |
0.0331 | - |
9-methoxy-7H-furo[3,2-g][1]benzopyran-7-one | DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | |
0.0538 | - |
9-methoxy-7H-furo[3,2-g][1]benzopyran-7-one | deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | |
0.0733 | - |
4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one | deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0011 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0012 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-(2-hydroperoxy-3-methylbut-3-en-1-yl)-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0026 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-(2-hydroperoxy-3-methylbut-3-en-1-yl)-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0049 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0052 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-(2-hydroperoxy-3-methylbut-3-en-1-yl)-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0056 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0061 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0079 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2,4-dihydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0082 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0092 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0102 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0102 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0109 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0113 | - |
DeISGylation activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-6,6-dimethoxy-3-methylhex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0117 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2,4-dihydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0117 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.013 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0131 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0154 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.016 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0174 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2,4-dihydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0193 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0211 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-6,6-dimethoxy-3-methylhex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.026 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0302 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[3-[(2E)-6,6-dimethoxy-3-methylhex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0441 | - |
deubiquitination activity, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | |
0.0464 | - |
substrate: LRLRGG 7-amido-4-methylcoumarin, pH 6.8, 37°C | Severe acute respiratory syndrome-related coronavirus | (2E)-1-[2-hydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one |